Frontiers in Clinical Drug Research - CNS and Neurological Disorders
View Sample
To Avail the Discount Please Click Below.
DEAL OF THE DAY:   US $48.3US $6930%
    Book Highlight

Editors: Atta-ur-Rahman , Zareen Amtul

Frontiers in Clinical Drug Research - CNS and Neurological Disorders

Volume 7

eBook: US $69 Special Offer (PDF + Printed Copy): US $117
Printed Copy: US $83
Library License: US $276
ISSN: 2451-8883 (Print)
ISSN: 2214-7527 (Online)
ISBN: 978-981-14-4750-1 (Print)
ISBN: 978-981-14-4752-5 (Online)
Year of Publication: 2020
DOI: 10.2174/97898114475251200701

Introduction

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.

The seventh volume of this series features reviews that cover the following topics related to the treatment of neurodegenerative diseases, epilepsy and stroke:

  1. -Fatty Acid Amides as a New Potential Therapeutic Agent in Multiple Sclerosis
  2. -Epileptic Seizures Detection Based on Non-Linear Characteristics Coupled with Machine Learning Techniques
  3. -Hampering Essential Tremor Neurodegeneration in Essential Tremor: Present and Future Directions
  4. -The Potential Therapeutic Role of the Melatoninergic System in Treatment of Epilepsy and Comorbid Depression
  5. -Modeling Neurodegenerative Diseases Using Transgenic Model of Drosophila
  6. -Genetic Basis in Stroke Treatment: Targets of Potent Inhibitors

Preface

- Pp. i
Atta-ur-Rahman and Zareen Amtul
Download Free

List of Contributors

- Pp. ii-iii (2)
Atta-ur-Rahman and Zareen Amtul
Download Free

Fatty Acid Amides as a New Potential Therapeutic Agent in Multiple Sclerosis

- Pp. 1-22 (22)
Nicola S Orefice

PDF Price: $15

View Abstract Purchase Chapter

Epileptic Seizures Detection Based on Non-linear Characteristics Coupled with Machine Learning Techniques

- Pp. 23-39 (17)
Firas Sabar Miften, Mohammed Diykh, Shahab Abdulla and Jonathan H. Green

PDF Price: $15

View Abstract Purchase Chapter

Hampering Essential Tremor Neurodegeneration in Essential Tremor: Present and Future Directions

- Pp. 40-71 (32)
Rania Aro, Pierre Duez, Amandine Nachtergael and Mario Manto

PDF Price: $15

View Abstract Purchase Chapter

The Potential Therapeutic Role of the Melatoninergic System in Treatment of Epilepsy and Comorbid Depression

- Pp. 72-102 (31)
Jana Tchekalarova, Dimitrinka Atanasova and Nikolai Lazarov

PDF Price: $15

View Abstract Purchase Chapter

Modeling Neurodegenerative Diseases Using Transgenic Model of Drosophila

- Pp. 103-128 (26)
Brijesh Singh Chauhan, Amarish Kumar Yadav, Roshan Fatima, Sangeeta Arya, Jyotsna Singh, Rohit Kumar and Saripella Srikrishna

PDF Price: $15

View Abstract Purchase Chapter

Genetic Basis in Stroke Treatment: Targets of Potent Inhibitors

- Pp. 129-146 (18)
Kanika Vasudeva and Anjana Munshi

PDF Price: $15

View Abstract Purchase Chapter

Subject Index

- Pp. 147-154 (8)
Atta-ur-Rahman and Zareen Amtul
Download Free

RELATED BOOKS

.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Frontiers in Clinical Drug Research-Dementia.
.Alzheimer
.Advances in Alzheimer Research.